2002
DOI: 10.1001/archderm.138.6.827
|View full text |Cite
|
Sign up to set email alerts
|

Immunosuppression and Skin Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
8
0

Year Published

2003
2003
2014
2014

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 20 publications
(9 citation statements)
references
References 6 publications
1
8
0
Order By: Relevance
“…BCCs are the second most frequent skin malignancy after SCC in this group of patients 21 . Literature data indicate that in the transplant patients skin cancers may have a more aggressive course 21,22 .…”
Section: Immunosuppressionmentioning
confidence: 96%
See 2 more Smart Citations
“…BCCs are the second most frequent skin malignancy after SCC in this group of patients 21 . Literature data indicate that in the transplant patients skin cancers may have a more aggressive course 21,22 .…”
Section: Immunosuppressionmentioning
confidence: 96%
“…BCCs are the second most frequent skin malignancy after SCC in this group of patients 21 . Literature data indicate that in the transplant patients skin cancers may have a more aggressive course 21,22 . Moreover, the incidence of nonmelanoma skin cancers (NMSCs) in that group increases with the length of follow‐up after transplantation, estimating that increase to approximately 100‐fold by 5 years after transplantation 23 .…”
Section: Immunosuppressionmentioning
confidence: 97%
See 1 more Smart Citation
“…Although the small numbers limit the conclusions we can draw from this observation, HIV infection as a risk factor for skin cancer recurrence needs further study. 15,16 …”
Section: Commentmentioning
confidence: 99%
“…18, 19 The incidence of basal cell carcinoma (BCC), the most common skin cancer, has been doubling every 14 years. 20 The risk for subsequent BCCs after an initial tumor is substantial, with 44% developing additional lesions within three years.…”
mentioning
confidence: 99%